(Q48410929)

English

A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with

scientific article published on 26 July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

hypoandrogenism

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

Florian Hiemeyer

object named as

Florian Hiemeyer

8

0 references

object named as

Stefan Arver

3

0 references

author name string

Hermann M Behre

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

Teuvo L J Tammela

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

Josep R Tolrá

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

Vincenzo Bonifacio

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

Michael Lamche

6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

Judy Kelly

7

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

European Testogel® Study Team

9

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

Louis J Gooren

11

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

publication date

26 July 2012

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

15

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

198-207

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Testosterone deficiency, insulin resistance and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Reproductive endocrinology: Late-onset hypogonadism: evidence for diagnostic criteria

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Identification of late-onset hypogonadism in middle-aged and elderly men.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Testosterone replacement therapy for late-onset hypogonadism

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Androgens and male aging: Current evidence of safety and efficacy

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Inflammatory markers in women with a recent history of gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

A critical evaluation of simple methods for the estimation of free testosterone in serum.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Onset of effects of testosterone treatment and time span until maximum effects are achieved

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial?

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Effects of testosterone gel followed by parenteral testosterone undecanoate on sexual dysfunction and on features of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Association between hormones and metabolic syndrome in older Italian men.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Sex hormones, inflammation and the metabolic syndrome: a population-based study

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Epidemiology: testosterone and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

HYPOGONADISM AND METABOLIC SYNDROME: IMPLICATIONS FOR TESTOSTERONE THERAPY

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Androgens and abdominal obesity

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Androgen treatment of abdominally obese men.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Androgens, insulin resistance and vascular disease in men.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS).

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

The Aging Males' Symptoms (AMS) scale: update and compilation of international versions

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2012.699562

21 January 2018

Identifiers

10.3109/13685538.2012.699562

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22834649

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48410929&oldid=1629729166"